吸水链霉菌BS-112产生的抗真菌活性物质的分离纯化与结构鉴别

【目的】分离纯化吸水链霉菌(Streptomyces hygroscopicus)BS-112产生的抗真菌活性物质,究明各活性组分的结构,测定其对黄曲霉的抑制作用,为该菌株及其产生的抗真菌活性物质的应用提供依据。【方法】通过大孔吸附树脂柱层析、硅胶柱层析及制备HPLC等方法,对该菌株产生的抗真菌活性物质进行分离纯化;利用质谱(MS)和核磁共振谱(NMR)解析各活性组分的结构;采用微量液体稀释法测定各活性组分对黄曲霉的最小抑菌浓度(MIC)和最小杀菌浓度(MFC)。【结果】从BS-112菌株发酵液中分离获得4个抗真菌活性组分,利用波谱技术确定其结构分别为Tetrins A和B、Tetramycins A和B。96孔板法测得这4个化合物对黄曲霉的MIC分别为3.13μg/mL、12.56μg/mL、1.56μg/mL、6.25μg/mL,MFC分别为6.25μg/mL、25.0μg/mL、3.13μg/mL、12.56μg/mL。【结论】BS-112菌株产生的抗真菌活性物质由Tetrins A和B、Ttramycins A和B 4个化合物组成,它们对黄曲霉均具有良好的抑制作用。     

抗真菌抗生素179M产生菌的分离鉴定和生理特性研究

从大亚湾海底沉积物中分离出一株具广谱抗真菌作用的曲霉（编号为179）,经初步鉴定为黄柄曲霉(Aspergillus flavipes),该曲霉最适生长温度为36℃,最适生长pH为6。其抗真菌代谢产物179M对酵母类真菌的最小抑菌浓度为0.78-12.5μg/mL,对皮肤感染真菌石膏样小孢子菌(Microsporum gypseum)的最小抑菌浓度为1.56μg/mL,179M还能抑制多种植物病原真菌的生长。     

抗真菌抗生素179M产生菌的分离鉴定和生理特性研究

从大亚湾海底沉积物中分离出一株具广谱抗真菌作用的曲霉（编号为179）,经初步鉴定为黄柄曲霉（Aspergillus flavipes),该曲霉最适生长温度为36℃,最适生长pH为6。其抗真菌代谢产物179M对酵母类真菌的最小抑菌浓度为0.79-12.5μg/mL,对皮肤感染真菌石膏样小孢子菌（Microsporum gypseum)的最小抑菌浓度为1.56μg/mL,179M还能抑制多种植物病原真菌的生长。     

抗真菌抗生素179M产生菌的分离鉴定和生理特性研究*

从大亚湾海底沉积物中分离出一株具广谱抗真菌作用的曲霉（编号为179）,经初步鉴定为黄柄曲霉(Aspergillus flavipes),该曲霉最适生长温度为36℃,最适生长pH为6。其抗真菌代谢产物179M对酵母类真菌的最小抑菌浓度为0.78-12.5μg/mL,对皮肤感染真菌石膏样小孢子菌(Microsporum gypseum)的最小抑菌浓度为1.56μg/mL,179M还能抑制多种植物病原真菌的生长。     

广西地区隐球菌感染的临床特征、菌种鉴定及体外抗真菌药物敏感性CSCD

目的分析广西地区隐球菌感染的临床特征、致病菌种鉴定及其体外药物敏感性。方法收集86例确诊隐球菌病患者(14例为HIV阳性,72例为HIV阴性)中分离出103株隐球菌及其患者资料并对其临床特征进行分析,使用MALDI-TOF MS和ITS区测序分子鉴定方法,92株被鉴定为新生隐球菌grubii变种,11株被鉴定为格特隐球菌。使用CLSI M27-A4方法对菌株进行常用抗真菌药物氟康唑、两性霉素B、5-氟胞嘧啶、伊曲康唑、伏立康唑、泊沙康唑和艾沙康唑体外药物敏感性测试。结果①86例患者(男性59名,女性27名),年龄为21~84岁,其中55人无基础疾病,31人有基础疾病。②由于目前对于隐球菌尚无泊沙康唑、艾沙康唑和两性霉素B的折点,因此参考了念珠菌属的数据,所有菌株对大多数抗真菌药物敏感。抗真菌药物对新生隐球菌grubii变种最低抑菌浓度范围为:氟康唑0.05~4μg/mL,两性霉素B 0.25~1μg/mL,5-氟胞嘧啶0.0625~2μg/mL,伊曲康唑0.0625~0.25μg/mL,伏立康唑0.0078~0.25μg/mL,泊沙康唑0.0313~0.5μg/mL,艾沙康唑0.0020~0.125μg/mL。抗真菌药物对格特隐球菌最低抑菌浓度范围为:氟康唑1~16μg/mL,5-氟胞嘧啶0.125~1μg/mL,两性霉素B 0.25~1μg/mL,伊曲康唑0.0625~0.25μg/mL,伏立康唑0.0156~0.125μg/mL,泊沙康唑0.0156~0.25μg/mL,艾沙康唑0.0078~0.125μg/mL。结论MALDI-TOF MS是一种快速可靠的鉴定隐球菌的方法。广西地区分离隐球菌对临床抗真菌药物敏感,抗真菌药敏试验有助于早期发现耐药菌株,对有效地治疗隐球菌病具有重要意义。     

黄花草木樨提取物抑菌活性初探

采用离体和活体试验方法分别测定了黄花草木樨不同溶剂提取物对12种植物病原真菌的抑菌活性.结果表明:各溶剂提取物对12种植物病原真菌均具有不同程度的抑菌活性,其中以乙酸乙酯提取物的抑菌活性最高,对油菜菌核病菌、玉米大斑病菌和白菜黑斑病菌抑制菌丝生长的EC50分别为0.62、0.83、0.64g/L,对稻瘟病菌和玉米大斑病菌抑制孢子萌发的EC50分别为0.67、0.97g/L.离体组织法测定表明其乙酸乙酯提取物对番茄灰霉病菌具有较高的保护和治疗作用,在浓度为5.0g/L时,防治效果分别为75.41%和59.18%(6d).活体试验表明乙酸乙酯提取物对小麦白粉病和小麦条锈病也有一定的保护作用,在浓度为10.0g/L时,防治效果分别为73.39%和63.27%.     

长裙竹荪抑菌活性物质的分离纯化及其抑菌效果

长裙竹荪Dictyophora indusiata是珍贵的食药用真菌,具有很强的抑菌作用,在天然防腐剂开发方面具有广阔的应用前景。本研究以长裙竹荪的抑菌活性为指标,通过萃取、3次不同流动相的硅胶柱层析、1次反相柱层析和薄层层析法对竹荪提取物进行分离纯化,得到一个抗菌活性强的单体化合物。根据核磁共振波谱等数据分析,推断该化合物为间苯三酚。以巨大芽孢杆菌和肠炎沙门氏菌为供试菌,用平板打孔法及原位抑菌法测定该化合物的抑菌效果,结果表明：该化合物对这两种菌有很强的抑制作用,半抑制浓度分别为83.06μg/mL和51.58μg/mL。本研究首次从长裙竹荪中获得具有抗菌活性的单体化合物间苯三酚,为竹荪天然抗菌物质的开发提供理论依据。     

嗜线虫致病杆菌的抑菌物质及抑菌活性

嗜线虫致病杆菌北京变种(Xenorhabdus nematophilavar.pekingense)是从北京地区采集的小卷蛾斯氏线虫(Steinernema carpocapsae)肠道内分离的共生细菌,具有自主知识产权,分离纯化出其发酵代谢物中的抗菌物质,进行抗菌活性测定,对研究该菌的抑菌机理以及开发利用具有重要意义。本文从该菌株代谢物中分离获得的抗菌物质经紫外光谱、红外光谱、核磁共振、高分辨质谱以及理化性质分析,鉴定为Xenocoumacin 1。用平板含毒培养基法测定了该物质对12种植物病原真菌的抑菌活性,研究表明,分离的活性物质具有较强的抑制活性,浓度在10μg/mL时,对黄瓜疫霉病菌、苎麻疫霉病菌、辣椒疫霉病菌,西葫芦灰霉病菌,苹果斑点落叶病菌的菌丝抑制率为100%。对草莓疫病病菌、苹果腐烂病菌、苹果褐斑病菌、蕃茄灰霉病菌、苹果轮纹病菌抑制率分别为86.8%、79.4%、79.5%、62.6%、53.6%;对其中6种真菌的EC50为0.25~4.17μg/mL,该物质对疫霉属真菌抑制作用最强,并能引起番茄晚疫病菌的菌丝生长畸形,原生质外溢。本文对开发新型生物杀菌剂的研究奠定了基础。     

对多烯类药物耐药的1株黄曲霉临床株耐药性的初步研究

目的对1株分离自疑似侵袭性肺曲霉病患者肺泡灌洗液的黄曲霉进行常用抗真菌药物敏感性的测定,判断其药物敏感性。方法以形态学方法对该菌株进行菌种鉴定;然后按照美国临床和实验室标准研究所(CLSI)的丝状真菌抗真菌药物敏感性试验方案M38-A,测定常用抗真菌药物对该菌株的最低抑菌浓度、最低杀菌浓度;同时以E-test法测定该菌对两性霉素B和伊曲康唑的敏感性。结果微量液基稀释法显示,两性霉素B或制霉菌素对该菌的MIC值均为4μg/ml,MFC值均为16μg/ml;伊曲康唑的MIC值为0.5μg/ml,MFC值为2μg/ml;特比萘芬的MIC为0.03μg/ml,MFC为0.03μg/ml。E-test法结果显示,该菌对伊曲康唑敏感,对两性霉素B耐药。结论临床上可以分离到对多烯类抗真菌药物耐药的黄曲霉株,应该引起重视。     

10种中药单体对球形孢子丝菌的体外抗真菌作用研究

目的观察10种中药单体对球形孢子丝菌体外抑菌效果。方法参照CLSI的制M38-A2(3rd),采用微量液基稀释法,检测10种中药单体对20株球形孢子丝菌的作用。结果 10种中药单体最小抑菌浓度(MIC)的几何均数范围为53.82μg/mL～1024μg/mL,大蒜素、小檗碱、苦参碱、蛇床子素和丹皮酚的抑菌活性最佳,几何均数分别依次为53.82μg/mL、84.45μg/mL、103.97μg/mL、137.19μg/mL和284.05μg/mL,大蒜素的抗菌作用最强,MIC的范围为16～128μg/mL。最小杀菌浓度(MFC)的范围为64μg/mL～1024μg/mL。大蒜素的MFC值最低,几何均数为415.87μg/mL。结论大蒜素、小檗碱、苦参碱、蛇床子素和丹皮酚对球形孢子丝菌具有一定的抑菌活性,不同中药单体抑菌活性存在差异。     

Investigations of Antibacterial,Antioxidant, and Antidiabetic Potential of Extract and Its Active Fractions from the Leaves of Horsfieldia spicata (Roxb.) J. Sinclair

This study was undertaken to analyse the potential bioactivities including antibacterial, antioxidant and antidiabetic derived from the methanolic extract and the column chromatography ethyl acetate fraction (AcOEt Fr) of Horsfieldia spicata leaves. Methanolic extract and 4 other fractions was calculated for total phenol and flavonoid contents along with tested for antibacterial, antioxidant and antidiabetic properties. Interestingly, the AcOEt Fr had the highest value for total flavonoid content and the best antioxidant, and antidiabetic activities. Therefore, the AcOEt Fr was further separated using column chromatography technique for obtaining 9 selected fractions namely fraction 1 (F1) - fraction 9 (F9) which were further tested. The results showed that the AcOEt column chromatography fractions namely F2, F3, F4 and F6 had the best clear inhibition antibacterial value against all bacterial tested. In addition, these fractions also exhibited better Minimum Inhibitory Concentrations (MIC) and Minimum Bactericidal Concentrations (MBC) values than others. Antioxidant, 2,2-diphenylpicrylhydrazyl (DPPH) assayed indicated that AcOEt Fr had the strongest IC₅₀ value of 47.30 μg/mL. Further, F4 column chromatography fraction showed the best inhibition against α-Glucosidase enzyme related to antidiabetic activity with an IC₅₀ value of 6.11 μg/mL. Liquid chromatography tandem-mass spectrometry (LC/MS/MS) analysis identified that F4 derived from AcOEt fraction had several compounds belonging to the flavonoid and phenolics such as 3′,5-dihydroxy-7,4′-dimethoxyflavone, 5,7-dihydroxy-3-(4′-hydroxybenzyl)chromone, and Kadsurenin I.     

An LC-MS/MS assay to determine plasma pharmacokinetics of cyclic thymic hexapeptide (cTP6) in rhesus monkeys

A robust and simple method for absolute quantification of a novel bidirectional immunomodulatory drug candidate, cyclic thymic hexapeptide (cTP6), in rhesus monkey plasma was developed and validated by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Plasma proteins were precipitated by adding four volumes of acetonitrile. Peptides in the supernatant were separated by liquid chromatography on an Agilent Zorbax Eclipse Plus-C18 chromatographic column with gradient elution using 0.1% formic acid in water (mobile phase A) and 0.1% formic acid in methanol (mobile phase B) at 0.2 mL/min. The analytes were identified by triple quadrupole mass spectrometry in positive ion-mode. The assay was linear over a concentration range of 10-5000 ng/mL for cTP6, with a lower limit of quantification (LLOQ) of 10 ng/mL. Intra- and inter-day precision of the assay at three concentrations were 1.51-7.70% with accuracy of 95.1-104.2%. The average recovery of cTP6 for three concentration levels was 59.6-64.0%. No significant matrix effect was observed. Peptide cTP6 was detected in plasma of live rhesus monkeys up to 6-8h after intra-muscular injection. The half-life was 2.24-2.95 h. The result revealed a nonlinear pharmacokinetic response to increasing doses of cTP6 (100, 200, 500 μg/kg). For the multiple dose study of cTP6, the drug did not accumulate during daily administration at 100 μg/kg for 7 consecutive days in rhesus monkeys.     

Dryoptkirbioside,A New Fructofuranoside Glycerol,and Other Constituents from Dryopteris kirbi Hook et Grav Rhizomes

A new fructofuranoside glycerol, dryoptkirbioside ( 1 ), along with thirteen known compounds ( 2 - 14 ), was isolated from the MeOH extract of Dryopteris kirbi rhizomes by silica gel column chromatography, Sephadex LH-20 column chromatography, and semipreparative HPLC. The structure of the new compound was determined by analyses of its spectroscopic data including nuclear magnetic resonance (NMR), and high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS) and chemical conversions. The hexane-soluble portion and the EAF_A fraction showed strong activities against lung (A549), breast (MCF-7), and cervical (HeLa) human cancer cell lines (IC₅₀ values ranging from 4.0 to 8.8 μg/mL). Aspidinol P ( 5 ) and aspidinol B ( 6 ) exhibited moderate to low cytotoxicity on the three cell lines (IC₅₀ values ranging from 20.4 to 58.7 μM). The MeOH extract and hexane-soluble portion had excellent activities against Staphylococcus aureus and Bacillus subtilis (MICs 11.7 and 23.4 μg/mL), whereas the AcOEt- and BuOH-soluble portions were significantly active on S. aureus (MICs 46.9 and 93.8 μg/mL). The main fractions EAF_B, EAF_C and nBF_B displayed excellent activity against S. aureus (MICs 11.7 and 23.4 μg/mL). Aspidinol B ( 6 ) had significant activity, while aspidinol P ( 5 ) was moderately active against S. aureus and B. subtilis (MICs 42.0 and 89.5 μM).     

Development and validation of a sensitive and selective UHPLC-MS/MS method for simultaneous determination of both free and total eicosapentaeonic acid and docosahexenoic acid in human plasma

A sensitive, selective, and quantitative method for the simultaneous determination of free and total eicosapentaeonic acid (EPA) and docosahexenoic acid (DHA) has been developed and validated in human plasma using fatty acid free human serum albumin as a surrogate matrix. Clean-up for free EPA and DHA employs a liquid-liquid extraction with hexane to remove plasma interferences and provide for cleaner chromatography. The method for total EPA and DHA requires a digestion of the triglycerides followed by liquid-liquid extraction with hexane. Ultra high performance liquid chromatography (UHPLC) technology on a BEH C18 stationary phase column with 1.7 μm particle size was used for chromatographic separation, coupled to tandem mass spectrometry (UHPLC-MS/MS). The method for free EPA and DHA was validated over the concentration range of 0.05-25 μg/mL, while total EPA and DHA concentration range was 0.5-250 μg/mL. The results from assay validation show that the method is rugged, precise, accurate, and well suited to support pharmacokinetic studies. To our knowledge, this work represents the first UHPLC-MS/MS based method that combines both free and total EPA and DHA with a relatively small sample volume (25 μL aliquot) and a run time of 1.5 min, facilitating automation and high throughput analysis.     

芽胞杆菌B13解养分效果研究

目的评价芽胞杆菌B13的功能。方法通过培养基及土壤培养分析其解钾、解磷的效果。结果芽胞杆菌B13培养7d后液体培养基中的有效磷含量（0．94μg／mL）比对照组（0．75μg/mL）增加25．33％,有效钾含量（0．54μg/mL）比对照组（0．31μg／mL）增加74．19％,解磷和解钾差异均有统计学意义（P〈0．01）。芽胞杆菌B13添加在灭菌土壤和不灭菌土壤中都具有明显的解磷、解钾功效,说明芽胞杆菌B13有较好的土壤定植能力。平板解磷试验证明芽胞杆菌B13同时具有解无机磷和有机磷的功效。结论芽胞杆菌B13具有很大的研究与开发价值。     

Simultaneous determination of thiamphenicol, florfenicol and florfenicol amine in eggs by reversed-phase high-performance liquid chromatography with fluorescence detection

A specific, sensitive and widely applicable reversed-phase high-performance liquid chromatography with fluorescence detection (RP-HPLC-FLD) method was developed for the simultaneous determination of thiamphenicol (TAP), florfenicol (FF) and florfenicol amine (FFA) in eggs. Samples were extracted with ethyl acetate-acetonitrile-ammonium hydroxide (49:49:2, v/v), defatted with hexane, followed by RP-HPLC-FLD determination. Liquid chromatography was performed on a 5 μm LiChrospher C(18) column using a mobile phase composed of acetonitrile (A), 0.01 M sodium dihydrogen phosphate containing 0.005 M sodium dodecyl sulfate and 0.1% triethylamine, adjusted to pH 4.8 by 85% phosphoric acid (B) (A:B, 35:65 v/v), at a flow rate of 1.0 mL/min. The fluorescence detector of HPLC was set at 224 nm for excitation wavelength and 290 nm for emission wavelength. Limits of detection (LODs) were 1.5 μg/kg for TAP and FF, 0.5 μg/kg for FFA in eggs; limits of quantitation (LOQs) were 5 μg/kg for TAP and FF, 2 μg/kg for FFA in eggs. Linear calibration curves were obtained over concentration ranges of 0.025-5.0 μg/mL for TAP with determination coefficients of 0.9997, 0.01-10.0 μg/mL for FF with determination coefficients of 0.9997 and 0.0025-2.50 μg/mL for FFA with determination coefficients of 0.9998, respectively. The recovery values ranged from 86.4% to 93.8% for TAP, 87.4% to 92.3% for FF and from 89.0% to 95.2% for FFA. The corresponding intra-day and inter-day variation (relative standard deviation, R.S.D.) found to be less than 6.7% and 10.8%, respectively.     

Validation of high-performance liquid chromatography-tandem mass spectrometry assays for the quantification of eribulin (E7389) in various biological matrices

This paper presents specific and sensitive high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) assays for the quantification of the novel anticancer agent eribulin in human plasma, whole blood, urine and faeces. These assays, developed to support clinical pharmacological studies with the drug, quantify eribulin concentration ranges of 0.2-100ng/mL for plasma, 0.5-100 ng/mL for whole blood and urine and 0.1-25 μg/g for faeces, using sample volumes of 500 μL or 250 μg (faeces). Samples were prepared with liquid-liquid extraction, separated on a C18 column with gradient elution and analysed with a triple quadrupole MS, in positive ion mode. A structural analogue of eribulin was used as internal standard for the quantification. The assays were linear with correlation coefficients (r(2)) of 0.99 and better, whereby the deviation from nominal concentrations ranged from -8.2 to 8.9% with CV values of maximally 14.2%. Stability assessments demonstrated that eribulin is stable at -20°C in plasma, whole blood, urine and faeces for at least 38, 4, 10.5 and 5 months, respectively. In conclusion, the validation results show that the assays are specific and accurate and can therefore adequately be applied to support clinical studies of eribulin.     

Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT)

A series of novel N-alkyl 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (6-15) was synthesized by means of phosphonylation of 3'-azido-3'-deoxythymidine (4) with P-chloromethylphosphonic ditriazolide (3) followed by a reaction with the appropriate amine. The synthesized phosphonamidates 6-15 were evaluated for their cytotoxic activity in two human cancer cell lines: oral (KB) and breast (MCF-7) using the sulforhodamine B (SRB) assay. The highest activity in KB human cancer cells was displayed by phosphonamidate 8 (IC(50)=5.8 μg/mL), however, this compound was less potent than the parent AZT (IC(50)=3.1 μg/mL). Phosphonamidate 10 showed only moderate activity (IC(50)=12.1 μg/mL) whereas the other phosphonamidates proved inactive. Similarly, the highest activity in MCF-7 human cancer cells was displayed by phosphonamidate 8 (IC(50)=3.7 μg/mL) but it proved somewhat less active than AZT (IC(50)=2.6 μg/mL). Some activity was also displayed by phosphonamidate 10 (IC(50)=12.8 μg/mL) but the other phosphonamidates were found inactive. Hydrolysis studies indicate that the synthesized phosphonamidates are likely to act as prodrugs of the parent nucleoside (AZT). Transport measurements showed that the most active phosphonamidates (8 and 10) were able to permeate across the intestinal epithelium in vitro. The apparent permeability coefficients determined in Caco-2 cell monolayers indicated that these compounds could be moderately absorbed in humans.     

Antimutagenic effects of subfractions of Chaga mushroom (Inonotus obliquus) extract

Inonotus obliquus is a mushroom commonly known as Chaga that is widely used in folk medicine in Siberia, North America, and North Europe. Here, we evaluated the antimutagenic and antioxidant capacities of subfractions of Inonotus obliquus extract. The ethyl acetate extract was separated by vacuum chromatography into three fractions, and the fraction bearing the highest antimutagenic activity was subsequently separated into four fractions by reversed phase (ODS-C18) column chromatography. The most antimutagenic fraction was then separated into two subfractions (subfractions 1 and 2) by normal phase silica gel column chromatography. Ames test analysis revealed that the subfractions were not mutagenic. At 50 μg/plate, subfractions 1 and 2 strongly inhibited the mutagenesis induced in Salmonella typhimurium strain TA100 by the directly acting mutagen MNNG (0.4 μg/plate) by 80.0% and 77.3%, respectively. They also inhibited 0.15 μg/plate 4NQO-induced mutagenesis in TA98 and TA100 by 52.6-62.0%. The mutagenesis in TA98 induced by the indirectly acting mutagens Trp-P-1 (0.15 μg/plate) and B(α)P (10 μg/plate) was reduced by 47.0-68.2% by the subfractions, while the mutagenesis in TA100 by Trp-P-1 and B(α)P was reduced by 70.5-87.2%. Subfraction 1 was more inhibitory than subfraction 2 with regard to the mutagenic effects of 4NQO, Trp-P-1, and B(α)P. Subfractions 1 and 2 also had a strong antioxidant activity against DPPH radicals and were identified by MS, 1H NMR and 13C NMR analyses as 3β-hydroxy-lanosta-8, 24-dien-21-al and inotodiol, respectively. Thus, we show that the 3beta-hydroxy-lanosta-8, 24-dien-21-al and inotodiol components of Inonotus obliquus bear antimutagenic and antioxidative activities.